These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32358512)

  • 1. A modular biomimetic strategy for the synthesis of macrolide P-glycoprotein inhibitors via Rh-catalyzed C-H activation.
    Chen L; Quan H; Xu Z; Wang H; Xia Y; Lou L; Yang W
    Nat Commun; 2020 May; 11(1):2151. PubMed ID: 32358512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modular Biomimetic Strategy Enabled Discovery of Simplified Pseudo-Natural Macrocyclic P-Glycoprotein Inhibitors Capable of Overcoming Multidrug Resistance.
    Liu B; Yu X; Liu L; Wang L; Wang J; Huang Q; Xu Z; Luo C; Lou L; Huang W; Yang W
    J Med Chem; 2023 Feb; 66(4):2550-2565. PubMed ID: 36728755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inside-out extracellular vesicles-like biomimetic magnetic nanoparticles for efficient screening P-Glycoprotein inhibitors to overcome cancer multidrug resistance.
    Zhang X; Jia L; Liu N; Zhao Y; Zhang T; Xie X
    Colloids Surf B Biointerfaces; 2023 Feb; 222():113134. PubMed ID: 36630772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pd-Catalyzed Decarboxylative Olefination: Stereoselective Synthesis of Polysubstituted Butadienes and Macrocyclic P-glycoprotein Inhibitors.
    Song B; Xie P; Li Y; Hao J; Wang L; Chen X; Xu Z; Quan H; Lou L; Xia Y; Houk KN; Yang W
    J Am Chem Soc; 2020 Jun; 142(22):9982-9992. PubMed ID: 32352771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rh-Catalyzed C-H alkylation enabling modular synthesis of CF
    Sun T; He S; Xu Z; Zuo J; Yu Y; Yang W
    Org Biomol Chem; 2021 Apr; 19(16):3589-3594. PubMed ID: 33908550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of aromatic amides with triazole-core as potent reversal agents against P-glycoprotein-mediated multidrug resistance.
    Qiu Q; Zhu J; Chen Q; Jiang Z; Xu J; Jiang X; Huang W; Liu Z; Ye J; Xu X
    Bioorg Chem; 2019 Sep; 90():103083. PubMed ID: 31255991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and evaluation of a novel series of inhibitors reversing P-glycoprotein-mediated multidrug resistance.
    Ghaleb H; Li H; Kairuki M; Qiu Q; Bi X; Liu C; Liao C; Li J; Hezam K; Huang W; Qian H
    Chem Biol Drug Des; 2018 Sep; 92(3):1708-1716. PubMed ID: 29786944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update.
    Dong J; Qin Z; Zhang WD; Cheng G; Yehuda AG; Ashby CR; Chen ZS; Cheng XD; Qin JJ
    Drug Resist Updat; 2020 Mar; 49():100681. PubMed ID: 32014648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversing agents for ATP-binding cassette (ABC) transporters: application in modulating multidrug resistance (MDR).
    Lee CH
    Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):43-52. PubMed ID: 14754411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vinorelbine on cisplatin resistance reversal in human lung cancer A549/DDP cells.
    Zhou YT; Li K; Tian H
    Asian Pac J Cancer Prev; 2013; 14(8):4635-9. PubMed ID: 24083716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators.
    Safa AR
    Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):1-17. PubMed ID: 14754408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three decades of P-gp inhibitors: skimming through several generations and scaffolds.
    Palmeira A; Sousa E; Vasconcelos MH; Pinto MM
    Curr Med Chem; 2012; 19(13):1946-2025. PubMed ID: 22257057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent inhibitors of transporter-dependent multidrug resistance (MDR).
    Teodori E; Dei S; Martelli C; Scapecchi S
    Curr Top Med Chem; 2010; 10(17):1715-31. PubMed ID: 20645921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of thiophenylbenzofuran derivatives as potential P-glycoprotein inhibitors.
    Hung CC; Chen CY; Wu YC; Huang CF; Huang YC; Chen YC; Chang CS
    Eur J Med Chem; 2020 Sep; 201():112422. PubMed ID: 32569926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug resistance transporters and modulation.
    Tan B; Piwnica-Worms D; Ratner L
    Curr Opin Oncol; 2000 Sep; 12(5):450-8. PubMed ID: 10975553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of 2-methyl N10-substituted acridones as selective inhibitors of multidrug resistance (MDR) associated protein in cancer cells.
    Mayur YC; Ahmad O; Prasad VV; Purohit MN; Srinivasulu N; Kumar SM
    Med Chem; 2008 Sep; 4(5):457-65. PubMed ID: 18782042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J; Fang X; Hao J; Sha X
    Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol, a specific glutathione S-transferase inhibitor, overcomes the multidrug resistance (MDR)-associated protein 1-mediated MDR in small cell lung cancer.
    Filomeni G; Turella P; Dupuis ML; Forini O; Ciriolo MR; Cianfriglia M; Pezzola S; Federici G; Caccuri AM
    Mol Cancer Ther; 2008 Feb; 7(2):371-9. PubMed ID: 18281520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of 2-((Pyridin-4-ylmethyl)amino)nicotinamide Derivatives as Potent Reversal Agents against P-Glycoprotein-Mediated Multidrug Resistance.
    Qiu Q; Shi W; Li Z; Zhang B; Pan M; Cui J; Dai Y; Huang W; Qian H
    J Med Chem; 2017 Apr; 60(7):2930-2943. PubMed ID: 28301155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of N-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-4-oxo-3,4-dihydrophthalazine-1-carboxamide derivatives as novel P-glycoprotein inhibitors reversing multidrug resistance.
    Qiu Q; Zhou J; Shi W; Kairuki M; Huang W; Qian H
    Bioorg Chem; 2019 May; 86():166-175. PubMed ID: 30710850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.